Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

NCT: NCT06003608 · TERMINATED

NCT IDNCT06003608
StatusTERMINATED
Start Date2024-02-19
Completion2025-01-01
SponsorNimble Science Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

Observational cross-sectional study in PD patients and healthy controls (HC) using an investigational medical device consisting of a passive small intestine microbiome aspiration (SIMBA) system (capsule) that is ingested orally and recovered together with the stools (home recovery) together with blood sampling (during the onsite visit).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑